GI Oncology
Perspectives
An aspirin a day ... for CRC?
What about that wonder drug – the ubiquitous aspirin? Should gastroenterologists be the ones to recommend or even prescribe aspirin?
From the Journals
Excess weight over lifetime hikes risk for colorectal cancer
Previous studies may have underestimated the risk for CRC because they have looked at excess weight at a single point.
From the Journals
Two rounds of FIT vs. single colonoscopy as a one-time CRC screening
Two FITs spaced 2 years apart could change the approach to colorectal cancer screening if it shows a mortality benefit, according to a preliminary...
From the Journals
Will serrated polyp detection rates be the next CRC metric?
Higher detection rates were associated with a significantly decreased risk for postcolonoscopy colorectal cancer.
Conference Coverage
What’s the future of microbiome therapies in C. diff, cancer?
Preventive treatments for C. diff recurrence are in phase 3 trials, and oncologists are investigating microbiome-based differences in...
From the Journals
AI-assisted colonoscopy cuts adenoma miss rate in half
The artificial intelligence-based computer-aided detection system was particularly adept at detecting small and subtle lesions.
From the AGA Journals
Registry data support lowering CRC screening age to 45
Existing research gaps on the rates of younger-onset colorectal neoplasia need to be addressed to support these recommendations.
From the Journals
Can green tea extract protect against colorectal adenomas?
Green tea extract taken over 3 years was well tolerated but had no significant effects, according to the results of a large randomized controlled...
From the Journals
RFA has long-lasting protective effects in esophageal cancer
A 10-year report from the United Kingdom shows the benefits are durable for patients with Barrett’s esophagus.
From the Journals
AGA Clinical Practice Update: Commentary on noninvasive CRC screening
How to tailor screening based on CRC risk, and how to be sure screening is effective.